Recurrent B Acute Lymphoblastic Leukemia Recruiting Phase 1 Trials for Palbociclib (DB09073)

IndicationStatusPhase
DBCOND0107328 (Recurrent B Acute Lymphoblastic Leukemia)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03472573Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaTreatment